Aberrant CD40-induced NF-κB activation in human lupus B lymphocytes

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Zhang, Wen ^a   Shi, Qun ^a   Xu, Xiaotian ^a   Chen, Hua ^a   Lin, Wei ^a   Zhang, Fengchun ^a   Zeng, Xiaofeng ^a   Zhang, Xuan ^a   Ba, Denian ^b   He, Wei ^b  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; I KAPPA B ALPHA; I KAPPA B BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR REL;

ADULT; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; BINDING AFFINITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ACTIVE TRANSPORT, CELL NUCLEUS; ADOLESCENT; ADULT; ANTIGENS, CD40; B-LYMPHOCYTES; CD40 LIGAND; CHILD; FEMALE; GENE EXPRESSION REGULATION; HUMANS; I-KAPPA B PROTEINS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MEMBRANE MICRODOMAINS; MIDDLE AGED; NF-KAPPA B; PALATINE TONSIL; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 84865413525     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041644     Document Type: Article

References (32)

1. Liu Z, Zou Y, Davidson A, (2011) Plasma cells in systemic lupus erythematosus: the long and short of it all. Eur J Immunol 41: 588-591.
2. Loh C, Pau E, Chang NH, Wither JE, (2011) An intrinsic B-cell defect supports autoimmunity in New Zealand black chromosome 13 congenic mice. Eur J Immunol 41: 527-536.
3. Bishop GA, Hostager BS, (2003) The CD40-CD154 interaction in B cell-T cell liaisons. Cytokine Growth Factor Rev 14: 297-309.
4. Hostager BS, (2007) Roles of TRAF6 in CD40 signaling. Immunol Res 39: 105-114.
5. Jabara HH, Weng Y, Sannikova T, Geha RS, (2009) TRAF2 and TRAF3 independently mediate Ig class switching driven by CD40. Int Immunol 21: 477-488.
6. Jabara H, Laouini D, Tsitsikov E, Mizoguchi E, Bhan A, et al. (2002) The binding site for TRAF2 and TRAF3 but not for TRAF6 is essential for CD40-mediated immunoglobulin class switching. Immunity 17: 265-276.
7. Crow MK, Kirou KA, (2001) Regulation of CD40 ligand expression in systemic lupus erythematosus. Curr Opin Rheumatol 13: 361-369.
8. Homig-Holzel C, Hojer C, Rastelli J, Casola S, Strobl LJ, et al. (2008) Constitutive CD40 signaling in B cells selectively activates the noncanonical NF-kappaB pathway and promotes lymphomagenesis. J Exp Med 205: 1317-1329.
9. de Sanctis JB, Garmendia JV, Chaurio R, Zabaleta M, Rivas L, (2009) Total and biologically active CD154 in patients with SLE. Autoimmunity 42: 263-265.
10. Koshy M, Berger D, Crow MK, (1996) Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J Clin Invest 98: 826-837.
11. Vakkalanka RK, Woo C, Kirou KA, Koshy M, Berger D, et al. (1999) Elevated levels and functional capacity of soluble CD40 ligand in systemic lupus erythematosus sera. Arthritis Rheum 42: 871-881.
12. Kato K, Santana-Sahagun E, Rassenti LZ, Weisman MH, Tamura N, et al. (1999) The soluble CD40 ligand sCD154 in systemic lupus erythematosus. J Clin Invest 104: 947-955.
13. Yellin MJ, D'Agati V, Parkinson G, Han AS, Szema A, et al. (1997) Immunohistologic analysis of renal CD40 and CD40L expression in lupus nephritis and other glomerulonephritides. Arthritis Rheum 40: 124-134.
14. Caproni M, Torchia D, Antiga E, Giomi B, Mercuri M, et al. (2007) The CD40/CD40 ligand system in the skin of patients with subacute cutaneous lupus erythematosus. J Rheumatol 34: 2412-2416.
15. Harigai M, Hara M, Fukasawa C, Nakazawa S, Kawaguchi Y, et al. (1999) Responsiveness of peripheral blood B cells to recombinant CD40 ligand in patients with systemic lupus erythematosus. Lupus 8: 227-233.
16. Grammer AC, Slota R, Fischer R, Gur H, Girschick H, et al. (2003) Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions. J Clin Invest 112: 1506-1520.
17. Boumpas DT, Furie R, Manzi S, Illei GG, Wallace DJ, et al. (2003) A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis. Arthritis Rheum 48: 719-727.
18. Dejica D I, Manea EM, (2006) Costimulatory molecule CD154 in systemic lupus erythematosus and rheumatoid arthritis. Therapeutic perspectives. Roum Arch Microbiol Immunol 65: 66-74.
19. Grammer AC, Lipsky PE, (2003) B cell abnormalities in systemic lupus erythematosus. Arthritis Res Ther 5 Suppl 4: S22-S27.
20. Ardila-Osorio H, Pioche-Durieu C, Puvion-Dutilleul F, Clausse B, Wiels J, et al. (2005) TRAF interactions with raft-like buoyant complexes, better than TRAF rates of degradation, differentiate signaling by CD40 and EBV latent membrane protein 1. Int J Cancer 113: 267-275.
21. Wu CJ, Conze DB, Li X, Ying SX, Hanover JA, et al. (2005) TNF-alpha induced c-IAP1/TRAF2 complex translocation to a Ubc6-containing compartment and TRAF2 ubiquitination. EMBO J 24: 1886-1898.
22. Xia Z P, Chen ZJ, (2005) TRAF2: a double-edged sword? Sci STKE 2005: e7.
23. Habelhah H, Takahashi S, Cho SG, Kadoya T, Watanabe T, et al. (2004) Ubiquitination and translocation of TRAF2 is required for activation of JNK but not of p38 or NF-kappaB. EMBO J 23: 322-332.
24. Mehta J, Genin A, Brunner M, Scalzi LV, Mishra N, et al. (2010) Prolonged expression of CD154 on CD4 T cells from pediatric lupus patients correlates with increased CD154 transcription, increased nuclear factor of activated T cell activity, and glomerulonephritis. Arthritis Rheum 62: 2499-2509.
25. Blossom S, Chu EB, Weigle WO, Gilbert KM, (1997) CD40 ligand expressed on B cells in the BXSB mouse model of systemic lupus erythematosus. J Immunol 159: 4580-4586.
26. Gladman DD, Ibañez D, Urowitz MB, (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29: 288-291.
27. Hillion S, Dueymes M, Youinou P, Jamin C, (2007) IL-6 contributes to the expression of RAGs in human mature B cells. J Immunol 179: 6790-6798.
28. Withers DR, Fiorini C, Fischer RT, Ettinger R, Lipsky PE, et al. (2007) T cell-dependent survival of CD20+ and CD20- plasma cells in human secondary lymphoid tissue. Blood 109: 4856-4864.
29. Grammer AC, McFarland RD, Heaney J, Darnell BF, Lipsky PE, (1999) Expression, regulation, and function of B cell-expressed CD154 in germinal centers. J Immunol 163: 4150-4159.
30. Cheng PC, Dykstra ML, Mitchell RN, Pierce SK, (1999) A role for lipid rafts in B cell antigen receptor signaling and antigen targeting. J Exp Med 190: 1549-1560.
31. Dykstra ML, Longnecker R, Pierce SK, (2001) Epstein-Barr virus coopts lipid rafts to block the signaling and antigen transport functions of the BCR. Immunity 14: 57-67.
32. Cherukuri A, Tzeng SJ, Gidwani A, Sohn HW, Tolar P, et al. (2004) Isolation of lipid rafts from B lymphocytes. Methods Mol Biol 271: 213-24.